Are equity markets set for a turnaround? - The 5 Minute WrapUp by Equitymaster
Investing in India - 5 Minute WrapUp by Equitymaster
PRINTER FRIENDLY | ARCHIVES

Are equity markets set for a turnaround? 

A  A  A

In this issue:
» US investors pull out money from stock funds
» Currency traders are relatively unscathed
» Will 2010 see India's first patented new drug?
» Recession raises threat of protectionism
» ...and more!

00:00
Investors who were hoping for a quick turnaround in the fortunes of equity markets will probably not like this. No, we are not talking valuations here. Infact, as per most experts, they appear cheap by any historical measure. What we are worried about is that there could be very few buyers left on the other side of the table. As per a leading business daily, US retail investors have pulled out a staggering US$ 72 bn from stock funds in the month of October alone. And worse still, if the past trends are any indication, they are not likely to return in a hurry. It is believed that US retail investors form the bulwark of the market and hence, their disenchantment with equities does not augur well for the long term performance of the US equity markets. This change in attitude though has not been sudden. The dot com crash, which marked the end of a 17-year bull run in the US stock markets, left a bitter taste for a lot of investors. Although they returned during the subsequent bull run, pouring in as much as US$ 65 bn per year between 2002 and 2005, the recent deep correction is perhaps the last straw. Thus, while the recent pullout points towards a deeper malaise, for the sake of the equity markets, let's just hope that this is indeed a temporary phenomenon.

------------------------- Investor Survey -------------------------
The Equitymaster Investor Survey (December 2008)
Make your collective opinion count. Take the Survey Now!
It's designed to take no more than 2 minutes of your precious time! Click here.

--------------------------------------------------------------------------

00:35
The biggest financial crisis since the Great Depression has resulted in several layoffs across industries around the world. The developed nations especially have been worse off. But in an effort to minimize layoffs and rationalize costs at the same time, corporates in the US have been coming out with various initiatives such as four-day workweeks, unpaid vacations, wage freezes, pension cuts and flexible work schedules. In fact, as reported in the International Herald Tribune (IHT), many of the employees are volunteering for pay cuts, it being a much preferred option than being asked to leave. Interestingly, the rationale behind these strategies is to have the required workforce at hand should the economy suddenly improve just as it had deteriorated so rapidly in October. The idea is to not cut too much. And corporates are being careful about hiring and firing, choosing to keep the productive workers on the payrolls.

01:12
Satyam's reputation is taking a nosedive. After serious corporate governance issues raised over the company's failed buyout of two firms owned by its chairman's family, it is in the limelight for the wrong reasons yet again. As per a leading business daily, it appears that at least one independent director had not fully signed off on the US$ 1.6 bn valuation placed on the two companies by the management of Satyam. While the proposal for acquisition had been cleared, the price at which it would be done had not been decided. What's more, another independent director seconded this news.

This development shows the management in an extremely poor light. However, it continues to stand by the fact that the deal was called off only because it was strongly opposed by its key shareholders. Whatever, be the case, it is apparent that the management of Satyam needs some serious lessons in good corporate governance practices.

01:29
While bankers, investment bankers and people of their ilk are struggling to hold on to their jobs, currency traders are having it relatively easy. As reported on Bloomberg, while bonuses, which account for the bulk of annual pay for traders and investment bankers, will fall an average 45% this year, currency traders will see declines of about 15% from 2007; a huge gap indeed. With the significant volatility in currencies, foreign-exchange markets have been witnessing robust growth.

Fathom some statistics on Bloomberg. Forex trading revenue at US commercial banks rose 66% in the second quarter from a year earlier. Global heads of foreign exchange trading will receive average bonuses of US$ 3.5 m to US$ 4.5 m, down 10% from last year. Not only that, foreign-exchange contracts traded at the CME Group Inc., the world's largest futures market, surged in September by 32% from a year earlier, to a notional value of US$ 111 bn. What's more, Deutsche Bank and UBS AG, the world's two largest currency traders, posted three consecutive quarters of record revenue from foreign exchange. Therefore, with the reputation of Wall Street reduced to tatters, it is hardly surprising that foreign-exchange trading was the only area that got away unblemished. And as the volatility is expected to continue, the scenario for the forex markets and traders only appears brighter.

02:08
As per reports, liquor and airlines business magnate, Vijay Mallya is in the race with Mexican billionaire and one of the world's richest men, Carlos Slim Helu among others to buy the Formula One (F1) team of Japanese auto company Honda. We wonder if this is the best use of the cash that Mr Mallya has at his disposal. Perhaps, he would have been better off injecting money into his fledgling airlines business.

02:16
As per the Economist, recession in the developed economies raises a serious threat. That of protectionism worldwide. Protectionism could be the biggest spanner in the wheels of globalisation that rests on the two planks of trade and capital flows. As per the World Bank, international trade is set to decline by 2% in 2009, while the net private capital flows to emerging economies are likely to fall by 50%. While world trade affects export oriented countries like China and Germany, capital flows affect emerging countries with current account deficits like India.

Emerging economies will protect themselves with higher import tariffs. They have sufficient scope to raise tariffs because for decades they have unilaterally reduced them. Developed economies will protect themselves with subsidies and bailouts to troubled industries. Both hinder globalisation.

What's the solution? A combination actually: Enlightened politics from US and China, conclusion of the Doha round, greater transparency about tariff barriers and macro economic stimulus in capital starved economies.

03:11
It is a well documented fact that the advent of the patent regime compelled many domestic pharma players to increase their efforts on R&D of new molecules. It has been almost four years now since the product patent law was introduced. Thus, who is likely to hold the distinction of introducing India's first patented drug? It seems neither Dr.Reddy's nor Ranbaxy but Glenmark instead. Glenmark in partnership with Napo Pharmaceuticals had been working on a drug called 'Crofelemer' for the treatment of HIV-associated diarrhea. Given that Napo will get a NDA (new drug application) for this drug in the US by 2010, Glenmark plans to make regulatory approvals in the rest of the world markets and expects approvals to start trickling in starting 2010. The company expects peak sales of US$ 80 m from these markets.

Source: Company Annual Reports

Interestingly, while Ranbaxy and Dr.Reddy's had started their R&D efforts before Glenmark entered into the scene, the latter has been very aggressive about its research strategy and because of the strength of its pipeline, has been able to ink several out-licensing deals with innovators. Dr.Reddy's does have an anti-diabetic molecule 'Balaglitazone' which is in Phase III trials. But the problem is that it belongs to a class of drugs which has run into trouble with the US FDA. Given that the US FDA has become very stringent in approving new drugs, the scenario is only expected to get tougher for domestic pharma players. In the meanwhile, Glenmark has something to cheer about!

04:13
If you are thinking that the financial firms in the US may be feeling sorry for the mess they've helped create, think again. Six of the financial firms that were recipients of the American government bailout still own and operate fleets of jets to carry executives to company events and sometimes even for their personal trips. According to a review of the Federal Aviation Administration records, American International Group (AIG), which has received about US$ 150 bn of aid from the government, has one of the largest fleets of 7 jets amongst its peers. But it is not alone. Five other financial companies that got a total of US$ 120 bn of assistance from tax payers money: Citigroup Inc., Wells Fargo and Co., Bank of America Corp., JPMorgan Chase and Co. and Morgan Stanley, all own aircrafts.

This despite last month when chief executives of the big three US auto companies, Ford Motor Co., General Motors Corp. and Chrysler Llc. received acrimonious criticism for flying to Washington on corporate jets to ask the government for a bailout. Looks like Wall Street is taking its time in learning a few lessons.

04:42
The Indian markets closed lower today by 2%. BSE Bankex and BSE Capital Goods (down 4% each) contributed to the decline. While the Asian markets also closed in the red, the European indices are trading mixed currently. As reported on Bloomberg, crude oil fell by 2% to US$ 39 a barrel on speculation that deepening global recession is reducing fuel demand in Asia. Gold fell by 1% to US$ 842 an ounce as the drop in crude prices reduced the appeal of the yellow metal as a hedge against inflation.

04:53  Today's investing mantra
"Time is the enemy of the poor business and the friend of the great business. If you have a business that's earning 20%-25% on equity, time is your friend. But time is your enemy if your money is in a low return business" - Warren Buffett
The 5 Minute WrapUp Premium is now Live!
A brand new initiative of Equitymaster, this is the Premium version of our daily e-newsletter The 5 Minute WrapUp.

Join us in this journey to uncover the sensible way of managing money and identifying investment opportunities across various asset classes including Stocks, Gold, Fixed Deposits... that over time can help you realize your life's goals...

Latest EditionGet Access
Recent Articles:
You've Heard of Timeless Books... Ever Heard of Timeless Stocks?
August 19, 2017
Ever heard of Lindy Effect? Find out how you can use it to pick timeless stocks.
Why NOW Is the WORST Time for Index Investing
August 18, 2017
Buying the index now will hardly help make money in stocks even in ten years.
This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)
August 17, 2017
A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.
This Company Beat the Business World's 'Three Killer Cs'
August 16, 2017
And what it has in common with beating the stock market too.

Equitymaster requests your view! Post a comment on "Are equity markets set for a turnaround?". Click here!

  

MOST POPULAR | ARCHIVES | TELL YOUR FRIENDS ABOUT THE 5 MINUTE WRAPUP | WRITE TO US

Copyright © Equitymaster Agora Research Private Limited. All rights reserved.

Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement

Disclosure & Disclaimer: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. The Author does not hold any shares in the company/ies discussed in this document. Equitymaster may hold shares in the company/ies discussed in this document under any of its other services.

This document is confidential and is supplied to you for information purposes only. It should not (directly or indirectly) be reproduced, further distributed to any person or published, in whole or in part, for any purpose whatsoever, without the consent of Equitymaster.

This document is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity, who is a citizen or resident or located in any locality, state, country or other jurisdiction, where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject Equitymaster or its affiliates to any registration or licensing requirement within such jurisdiction. If this document is sent or has reached any individual in such country, especially, USA, the same may be ignored.

This document does not constitute a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Our research recommendations are general in nature and available electronically to all kind of subscribers irrespective of subscribers' investment objectives and financial situation/risk profile. Before acting on any recommendation in this document, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek professional advice. The price and value of the securities referred to in this material and the income from them may go down as well as up, and subscribers may realize losses on any investments. Past performance is not a guide for future performance, future returns are not guaranteed and a loss of original capital may occur. Information herein is believed to be reliable but Equitymaster and its affiliates do not warrant its completeness or accuracy. The views/opinions expressed are our current opinions as of the date appearing in the material and may be subject to change from time to time without notice. This document should not be construed as an offer to sell or solicitation of an offer to buy any security or asset in any jurisdiction. Equitymaster and its affiliates, its directors, analyst and employees will not be responsible for any loss or liability incurred to any person as a consequence of his or any other person on his behalf taking any decisions based on this document.

As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407